## a b s t r a c t We report the synthesis and in vitro activity of a series of novel substituted N-{3-[(1,1-dioxido-1,2benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs. These analogs showed potent inhibitory activity against Kv1.3. Several demonstrated similar potency to the known Kv1.3 i
N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs as potent Kv1.3 inhibitors. Part 1
✍ Scribed by Curt D. Haffner; Stephen A. Thomson; Yu Guo; Lee T. Schaller; Sharon Boggs; Scott Dickerson; Jeff Gobel; Dan Gillie; J. Patrick Condreay
- Book ID
- 104004963
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 414 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
✦ Synopsis
We report the synthesis and in vitro activity of a series of novel N-{3-[(1,1-dioxido-1,2-benzothiazol-3-yl)(phenyl)amino]propyl}benzamide analogs. These analogs showed potent inhibitory activity against Kv1.3. Several compounds, including compound 8b, showed similar potency to the known Kv1.3 inhibitor PAP-1 when tested under the IonWorks patch clamp assay conditions.
📜 SIMILAR VOLUMES
## Abstract A series of substituted 3‐amino‐1,2‐benzothiazole dioxides (I) is designed and synthesized.
## Abstract Two benzodiazepine CCK antagonists __N__‐(2,3‐dihydro‐1‐[^14^C]methyl‐2‐oxo‐5‐phenyl‐1H 1,4‐benzodiazepin‐3‐yl)‐benzamide **2** and __N__‐(2,3‐dihydro‐1‐[^14^C]methyl‐2‐oxo‐5‐phenyl‐1H‐1,4‐benzodiazepin‐3‐yl)‐[^14^C]methyl‐benzamide **3** were synthesized in high yields through the reac